For both sides

Ancillary cannabis businesses: how they are bought, sold, and valued

Federal and state law current as of September 2026 — verify with counsel.

An ancillary cannabis business sells goods or services to licensed cannabis operators without growing, making, or selling marijuana itself. It usually needs no cannabis licence, so a sale needs no regulator approval and is outside 280E. It is valued like an ordinary company in its sector, then discounted for customer credit risk, concentration, and the fact that SBA loans are generally closed to marijuana-focused suppliers.

Key takeaways

  • SBA SOP 50 10 8, effective 1 June 2025, makes a supplier ineligible if its products or services are used in connection with illegal activity, unless that use is completely outside its intended market.
  • Hydrofarm reported second-quarter 2026 net sales of $23.2 million, down 40.9% from a year earlier, citing industry oversupply, which shows how cultivation distress reaches equipment suppliers.
  • WM Technology reported second-quarter 2026 revenue of $42.4 million and 5,040 average monthly paying clients, down from 5,241, citing churn in established markets.
  • Innovative Industrial Properties, the largest listed cannabis landlord, reported $63.3 million of revenue for the second quarter of 2026, up 0.7% year over year.
  • In Alternative Health Care Advocates (2018) the Tax Court held that a management company running a dispensary's operations was itself trafficking under 280E.

What counts as an ancillary cannabis business, and does it need a licence?

An ancillary business serves the cannabis industry without touching the plant. It never takes title to or possession of marijuana. In most states that means no cannabis licence, no ownership vetting by the cannabis regulator, and no regulator approval when the company is sold.

CategoryExamplesCannabis licence?
Packaging and equipmentChild-resistant packaging, labels, lighting, HVAC, benches, extraction equipment, nutrients, hydroponic retailNo
SoftwarePoint of sale, seed-to-sale and compliance software, menus and marketplaces, payments and HR toolsNo, though track-and-trace integrators are vetted by the system vendor
Professional servicesAccounting, legal, compliance consulting, security, staffing, marketing, constructionNo, but on-site contractors may need badges or visitor logging
Management and brand licensingManagement services companies, brand and intellectual property licensorsOften treated as an owner or true party of interest
Real estateLandlords, sale-leaseback investors, REITsNo in most states; landlords may need disclosure

The last two rows are where “ancillary” can stop being true. Regulators look at control and at how the supplier is paid. New York’s guidance, for example, warns that a party receiving payments from a licensee above the greatest of 10% of the licensee’s revenue, 50% of its net profit, or $250,000 in a calendar year becomes a true party of interest, and that a management services agreement between licensees creates a financial and controlling interest. A supplier paid a flat, market-rate fee stays ancillary. A supplier paid a share of profits may not.

How do ancillary businesses make money, and what are the risks?

They earn ordinary business margins, tax-deductible expenses included, from customers who are under unusual financial stress. The model works when the supplier gets paid. Three risks define the category:

  • Receivables. Licensed operators cannot use federal bankruptcy and have little access to credit, so they stretch suppliers. Collection in a receivership is slow and partial.
  • Concentration. Many ancillary firms depend on a handful of multi-state operators or on one state’s market.
  • Derived demand. When wholesale prices fall, growers stop building and stop buying.

Public filings show the third risk clearly. Hydrofarm, a hydroponic equipment maker and distributor, reported second-quarter 2026 net sales of $23.2 million, down 40.9% from $39.2 million a year earlier, citing industry oversupply and discontinued distributed brands. GrowGeneration, a hydroponic retailer that has shifted toward commercial customers, reported $43.2 million of net sales for the same quarter, up 5.5%, its third straight quarter of year-over-year growth. Same end market, very different results. How oversupply works through the chain is covered in how oversupply and price compression affect value.

Packaging and equipment businesses

These are distribution and light manufacturing companies with a regulatory twist. Packaging must meet each state’s child-resistance, opacity, and labelling rules, so a rule change can strand inventory overnight or create a rush of reorders. Equipment sales follow new licence issuance and facility construction, so revenue is lumpy and tied to state licensing calendars.

What buyers check:

  1. Gross margin by product line, and how much is imported and exposed to tariffs and freight.
  2. Inventory ageing, especially state-specific packaging that a rule change has made obsolete.
  3. Customer credit terms, deposits taken on equipment orders, and warranty obligations.
  4. Whether products are “primarily intended or designed” for marijuana use, which matters for SBA eligibility and sometimes for payment processing.
  5. Any equipment leases or financing the company has extended to customers. See equipment financing.

Software and services businesses

Software companies are valued on recurring revenue, churn, and customer acquisition cost, as anywhere else. The cannabis difference is a shrinking or consolidating customer count in mature states. WM Technology, which operates the Weedmaps marketplace, reported second-quarter 2026 revenue of $42.4 million, down from $44.8 million, and 5,040 average monthly paying clients, down from 5,241, citing churn in established markets. A small private software vendor should expect a buyer to ask the same questions: net revenue retention, logo churn by state, and how many customers are behind on payment.

For point-of-sale and compliance software, integration with state track-and-trace systems is an asset and a dependency. A state switching system vendors forces re-integration.

Service firms such as accounting, compliance, security, and staffing are valued on seller’s discretionary earnings. The issues are owner dependence, non-solicitation of staff and clients, and whether contracts can be assigned. Staffing and management firms need a close look at whether their people perform the licensee’s core operations, because that affects both regulatory status and tax, as discussed below.

Cannabis real-estate holdings

A building leased to a licensed operator is the most common ancillary asset in a sale. It is valued on net operating income and a capitalisation rate that reflects the tenant’s credit and the limited pool of lenders. The detail is on cannabis property values and cap rates.

Scale exists here. Innovative Industrial Properties, the largest listed cannabis landlord, reported total revenue of $63.3 million for the second quarter of 2026, up 0.7% from a year earlier, with new leases and rent escalators partly offset by property sales. The same release describes a $270 million investment in a life-science real estate company, which shows a cannabis landlord spreading its exposure beyond the sector.

For a private owner the questions are practical. Is the rent above what a non-cannabis tenant would pay, and if so, what is the building worth if the tenant fails? Is the build-out reusable? Does the mortgage permit a cannabis tenant? Many owner-operators hold the property in a separate entity, which lets them sell the operating company and keep the building, sell both, or raise cash through a sale-leaseback. Those choices are compared in selling a cannabis business with real estate.

The SBA nuance for indirect marijuana businesses

Ancillary does not mean SBA-eligible. Earlier SBA guidance used a defined term, the indirect marijuana business, for a company that earned any gross revenue from selling products or services to plant-touching customers, as Marijuana Moment’s comparison of the versions describes. SOP 50 10 8, effective 1 June 2025, drops the defined term but keeps a broad test. Under the SOP text:

  • A business is ineligible if it makes, sells, services, distributes, or promotes products or services used in connection with illegal activity, unless that use is “completely outside of the Applicant’s intended market”.
  • A business selling smoking devices or similar products primarily intended or designed for marijuana use, or marketed that way, is ineligible.
  • Real estate pledged for an SBA loan may not be leased to a business the borrower knows is engaged in federally illegal activity. The SOP’s example is a marijuana dispensary.
BusinessLikely SBA position
General HVAC, electrical, or security contractor with a few cannabis clientsArguable; the lender must be satisfied cannabis is outside the intended market
Packaging, software, or consulting firm built to serve licensed marijuana operatorsIneligible
Hydroponic store selling to home gardeners and commercial growersDepends on marketing and customer mix
Landlord with a marijuana tenantProperty cannot secure an SBA loan

The SOP does not turn on the drug schedule, so the April 2026 move of state-licensed medical marijuana to Schedule III did not change it. The full analysis is on why SBA and banks are unavailable. The practical point for a seller: do not describe the business as SBA-eligible unless a lender has reviewed it.

How is an ancillary cannabis business valued?

Use the ordinary multiples for its sector, whether distribution, software, professional services, or real estate, applied to normalised EBITDA or seller’s discretionary earnings. Then adjust for cannabis exposure:

  • Write down receivables from licensed operators by age and by the customer’s condition before applying any multiple.
  • Discount for customer and state concentration.
  • Credit any non-cannabis revenue. Diversified customers widen both the buyer pool and the lender pool.
  • Reflect the financing constraint. Without SBA money, more of the price is paid in cash, seller notes, or earn-outs.

The summary table on valuation methods by licence type places ancillary companies alongside the licensed types.

Who buys ancillary cannabis businesses?

Competitors rolling up a fragmented niche, mainstream companies in the same trade that want a cannabis customer base, software consolidators, real-estate investors, and cannabis operators bringing a service in-house. Investors who want cannabis exposure without licensing, 280E, or plant-touching risk are a distinct group, and the trade-offs for them are set out in plant-touching vs ancillary investment.

Selling considerations

  1. Produce a receivables ageing by customer, with collection history, and write off what will not be collected before a buyer does it for you.
  2. Show revenue by customer, by state, and by cannabis versus non-cannabis.
  3. Check customer and supplier contracts for assignment and change-of-control clauses.
  4. Put key staff on enforceable confidentiality and non-solicitation terms. See non-compete and non-solicit.
  5. If you have any profit-share or management arrangement with a licensee, have counsel confirm how the regulator classifies it before going to market.

Buyer diligence specific to ancillary businesses

  • Is it really ancillary? Read every contract with a licensee for control rights, profit shares, and options to acquire equity.
  • Customer health. Check the largest customers for tax liens, receiverships, and licence actions.
  • Banking and payments. Confirm the bank and payment processor know the customer base. Accounts opened without disclosure get closed.
  • Insurance. Review exclusions for cannabis-related work.
  • State disclosure duties. Some states require licensees to disclose major vendors, lenders, and landlords. Confirm the target’s customers have done so.

Transfer and approval quirks

Most ancillary sales close like any private company sale, with no cannabis regulator involved and no waiting period. Exceptions: a management company or brand licensor listed as a true party of interest on a customer’s licence, a landlord whose identity the regulator has on file, and lenders with disclosed financial interests. In those cases the licensee customer may need to file a notice or seek approval before the ancillary company changes hands, and the buyer’s owners may be vetted.

280E exposure

An ancillary company that never buys, sells, or handles marijuana is generally analysed as outside section 280E and deducts ordinary expenses. The line is crossed by doing the licensee’s work. In Alternative Health Care Advocates v. Commissioner (2018) the Tax Court held that a management company whose employees handled a dispensary’s purchasing, sales, and daily operations was itself trafficking, and it disallowed the management company’s deductions. Staffing, management, and “employee leasing” companies should be reviewed against that case. Other licence types are compared in 280E by licence type.

This page is educational and is not legal or tax advice. If you own an ancillary company and want to understand who would buy it, a confidential intro call is the place to start.

Frequently asked questions

Does an ancillary cannabis business need a cannabis licence?

Usually not, because it never possesses or sells marijuana. There are exceptions. Some states require vendor registrations, badges for contractors who work inside licensed premises, or disclosure of service providers paid a share of revenue. A management company that controls a licensee or shares its profits can be treated as an owner or true party of interest and must then be vetted like one.

Are ancillary cannabis companies subject to 280E?

Generally no. Section 280E applies to a business that consists of trafficking in Schedule I or II controlled substances. A packaging supplier, software vendor, or unrelated landlord does not buy or sell marijuana. The boundary is control. The Tax Court held in 2018 that a management company whose staff ran a dispensary's purchasing and sales was itself trafficking and lost its deductions.

Can a buyer get an SBA loan to acquire an ancillary cannabis business?

Often not. SBA's lender handbook treats a business as ineligible if it makes, sells, services, distributes, or promotes products or services used in connection with illegal activity, unless that use is completely outside its intended market. A company whose target market is licensed marijuana operators fails that test. A general contractor or HVAC firm with a few cannabis clients has a better argument, but the lender decides.

Why do ancillary cannabis businesses sell for less than similar companies in other industries?

Mainly because of who owes them money. Licensed operators have limited access to credit and no access to federal bankruptcy, so suppliers carry slow and doubtful receivables. Buyers write those down before applying a multiple. Heavy dependence on a few customers, exposure to one oversupplied state, and the narrow pool of lenders willing to finance the purchase all push prices lower.

Is cannabis real estate an ancillary business?

Yes, when the owner is only a landlord. Owning a building leased to a licensed operator does not require a cannabis licence in most states and is generally treated as outside 280E. It still carries cannabis risk: the tenant's credit, the property's specialised build-out, and lending restrictions. SBA rules bar property pledged for an SBA loan from being leased to a marijuana business.

Sources

  1. U.S. Small Business Administration — SOP 50 10 8, Lender and Development Company Loan Programs (effective 1 June 2025) — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
  2. Partner ESI — hosted copy of SOP 50 10 8 (effective 1 June 2025) — https://www.partneresi.com/wp-content/uploads/2023/10/SOP-50-10-8-effective-6.1.2025-Final.pdf
  3. Marijuana Moment — Marijuana Businesses Are Ineligible For Federal Loans, SBA Clarifies In Updated Guidance (2025) — https://www.marijuanamoment.net/marijuana-businesses-are-ineligible-for-federal-loans-sba-clarifies-in-updated-guidance-undoing-reckless-biden-policies/
  4. Hydrofarm Holdings Group — Second Quarter 2026 Results (14 Aug 2026) — https://www.globenewswire.com/news-release/2026/08/14/3345602/0/en/hydrofarm-holdings-group-announces-second-quarter-2026-results.html
  5. GrowGeneration — Second Quarter 2026 Financial Results (11 Aug 2026) — https://ir.growgeneration.com/news-events/press-releases/detail/269/growgeneration-reports-second-quarter-2026-financial-results
  6. WM Technology — Second Quarter 2026 Financial Results (6 Aug 2026) — https://www.businesswire.com/news/home/20260806563994/en/WM-Technology-Inc.-Reports-Second-Quarter-2026-Financial-Results
  7. Innovative Industrial Properties — Second Quarter 2026 Results (3 Aug 2026) — https://www.businesswire.com/news/home/20260802769895/en/Innovative-Industrial-Properties-Reports-Second-Quarter-2026-Results
  8. New York Office of Cannabis Management — OCM Academy 2, true party of interest payment thresholds (15 Nov 2023) — https://cannabis.ny.gov/system/files/documents/2025/12/chip-academy-1.2-microbusiness-overview.pdf
  9. CourtListener — Alternative Health Care Advocates v. Commissioner, 151 T.C. 225 (2018) — https://www.courtlistener.com/opinion/4575880/alternative-health-care-advocates-v-commissioner/
  10. Cornell LII — 26 U.S.C. 280E — https://www.law.cornell.edu/uscode/text/26/280E